Company profile for Spectral Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Spectral’s vision is to provide a personalized approach that will enable vastly improve outcomes for patients with septic shock by combining a targeted diagnostic test and therapy. It is widely known that endotoxin is a trigger of sepsis. Spectral has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin™ PMX-20R), for the treatment of patients with septic shock and endotoxemia (measured by the Compan...
Spectral’s vision is to provide a personalized approach that will enable vastly improve outcomes for patients with septic shock by combining a targeted diagnostic test and therapy. It is widely known that endotoxin is a trigger of sepsis. Spectral has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin™ PMX-20R), for the treatment of patients with septic shock and endotoxemia (measured by the Company’s Endotoxin Activity Assay (EAA™)).Spectral strives to exceed the highest ethical, financial and scientific standards in all our operations and activities.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
135 The West Mall, Unit 2, Toronto, ON M9C 1C2, CA
Telephone
Telephone
1.888.426.4264
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/07/3183570/0/en/Spectral-Medical-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
07 Nov 2025

https://www.globenewswire.com/news-release/2025/09/29/3157929/0/en/Spectral-Medical-Inc-Files-Base-Shelf-Prospectus-and-Revised-AIF.html

GLOBENEWSWIRE
29 Sep 2025

https://www.globenewswire.com/news-release/2025/09/16/3150670/0/en/Spectral-Medical-Announces-Publication-of-EDEN-Observational-Study.html

GLOBENEWSWIRE
16 Sep 2025

https://www.globenewswire.com/news-release/2025/09/08/3146038/0/en/Spectral-Medical-Sponsors-Unite-for-Sepsis-Symposium-Chicago-September-8-9-2025.html

GLOBENEWSWIRE
08 Sep 2025

https://www.globenewswire.com/news-release/2025/08/25/3138361/0/en/Spectral-Medical-Receives-US-3-Million-From-Vantive.html

GLOBENEWSWIRE
25 Aug 2025

https://www.globenewswire.com/news-release/2025/08/12/3132084/0/en/Spectral-Medical-and-Vantive-Announce-Topline-Results-from-Spectral-s-Tigris-Trial-Evaluating-PMX-Hemoadsorption-Therapy-for-Endotoxic-Septic-Shock.html

GLOBENEWSWIRE
12 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty